Abbas Maleki
Overview
Explore the profile of Abbas Maleki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khoshnood S, Haddadi M, Sadeghifard N, Maleki A, Kouhsari E, Valadbeigi H
BMC Infect Dis
. 2025 Feb;
25(1):207.
PMID: 39939941
Background: Antibiotic heteroresistance is a common phenotype observed in a variety of pathogenic bacteria such as K. pneumonia: A subpopulation of cells with a higher MIC than the dominant population...
2.
Altafi M, Beig M, Sami F, Maleki A, Kaviar V, Shahryari A, et al.
Infect Disord Drug Targets
. 2024 Oct;
PMID: 39440733
Background: The understanding of the antibiotic resistance status of environmental nonO1/nonO139 V. cholerae [NOVC] in relation to other illnesses, which can vary in severity from mild to life-threatening, is limited....
3.
Ghasemi F, Kardan-Yamchi J, Heidary M, Karami-Zarandi M, Akrami S, Maleki A, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 May;
36:100451.
PMID: 38764556
The bacterial pathogen is responsible for the ongoing global tuberculosis (TB) epidemic. Bacille Calmette-Guérin (BCG), the only currently approved TB vaccine, is successful in preventing disseminated disease in newborns. However,...
4.
Abbasian S, Heidari H, Tadi D, Kardan-Yamchi J, Taji A, Darbandi A, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Apr;
35:100430.
PMID: 38560029
Drug resistance among (MTB) strains is a growing concern in developing countries. We conducted a comprehensive search for relevant studies in Iran on PubMed, Scopus, and Embase until June 12,...
5.
Nazari M, Mahmoodi M, Kouhsari E, Shariati M, Maleki A
Clin Lab
. 2024 Feb;
70(2).
PMID: 38345980
Background: Bacterial persisters are non- or slow-growing phenotypic variants that may be responsible for recalcitrance and relapse of persistent infections and antibiotic failure. In Escherichia coli, mqsRA is a well-known...
6.
Heidari H, Kalantari P, Sholeh M, Pour S, Darbandi A, Maleki A, et al.
Iran J Public Health
. 2023 Dec;
52(11):2286-2298.
PMID: 38106824
Background: Non-tuberculous mycobacteria (NTM) infections have been continuously increasing as major concerns of public health in Iran. Because innate resistance of NTM species, the treatment of these infections is difficult...
7.
Valadbeigi H, Khoshnood S, Negahdari B, Maleki A, Mohammadinejat M, Haddadi M
Oral Dis
. 2023 Nov;
30(6):3582-3590.
PMID: 38009960
Background: Fusobacterium nucleatum (F. nucleatum) is an integral component of supra- and subgingival biofilms, especially more prevalent in subgingival areas during both periodontal health and disease. Aims: In this review,...
8.
Valadbeigi H, Sadeghifard N, Kaviar V, Haddadi M, Ghafourian S, Maleki A
Ann Clin Microbiol Antimicrob
. 2023 Oct;
22(1):89.
PMID: 37798613
Background: Biofilm formation by Pseudomonas aeruginosa (P. aeruginosa) is known to be characteristic of this organism. This bacterium is considered one of the most life-threatening bacteria and has been identified...
9.
Khoshnood S, Pakzad R, Kaviar V, Hashemian M, Karamollahi S, Sadeghifard N, et al.
Clin Lab
. 2023 Jul;
69(7).
PMID: 37436391
Background: A high resistance rate to clarithromycin usually leads to failure to eradicate Helicobacter pylori. The aim of the present study was to review recent data on H. pylori resistance...
10.
Ghasemian S, Karami-Zarandi M, Heidari H, Khoshnood S, Kouhsari E, Ghafourian S, et al.
J Clin Lab Anal
. 2023 Feb;
37(4):e24850.
PMID: 36808649
Background: Burn injuries result in disruption of the skin barrier against opportunistic infections. Pseudomonas aeruginosa is one of the main infectious agents colonizing burn wounds and making severe infections. Biofilm...